Oncotype DX breast testing
Ended Awarded Last action
- Contract number
- HT001418F0150
- Awardee
-
Genomic Health, Inc. UEI RHN3L7SBF7J6
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $13,816
Award facts
- Contract value 100% obligated
- $13,815.84 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q403 Medical- Evaluation/Screening
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Fort Belvoir, VA 22060, USA
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HT001418F0150?
HT001418F0150 was awarded to Genomic Health, Inc. by Defense Health Agency (Department of Defense) on March 30, 2018.
How much is contract HT001418F0150 worth?
The government has obligated $13,816 on HT001418F0150.
Is contract HT001418F0150 an order under another contract?
Yes. HT001418F0150 is a BPA call under HT001416A0144, a blanket purchase agreement.
Was contract HT001418F0150 competed?
The extent of competition for HT001418F0150 was competed under sap. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award